X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anti-thymocyte globulin (610) 610
index medicus (576) 576
humans (516) 516
transplantation (356) 356
male (294) 294
female (293) 293
hematology (282) 282
antithymocyte globulin (236) 236
adult (231) 231
middle aged (220) 220
immunosuppressive agents - therapeutic use (211) 211
antilymphocyte serum - therapeutic use (202) 202
immunology (202) 202
adolescent (156) 156
bone-marrow-transplantation (156) 156
animals (155) 155
oncology (136) 136
treatment outcome (135) 135
immunosuppression (129) 129
child (127) 127
versus-host-disease (125) 125
surgery (122) 122
retrospective studies (121) 121
stem-cell transplantation (111) 111
aplastic anemia (108) 108
aged (105) 105
immunosuppressive therapy (97) 97
child, preschool (93) 93
rabbit antithymocyte globulin (91) 91
antilymphocyte serum - administration & dosage (90) 90
cyclosporine (90) 90
rabbits (87) 87
therapy (86) 86
anemia, aplastic - therapy (83) 83
transplantation, homologous (83) 83
analysis (81) 81
stem cells (78) 78
graft rejection - prevention & control (77) 77
colony-stimulating factor (75) 75
graft vs host disease - prevention & control (72) 72
immunosuppressive agents - administration & dosage (72) 72
immunotherapy (72) 72
young adult (72) 72
recipients (70) 70
antilymphocyte serum - adverse effects (69) 69
hematopoietic stem cells (69) 69
kidney transplantation (69) 69
unrelated donors (69) 69
health aspects (68) 68
care and treatment (67) 67
induction (67) 67
risk factors (66) 66
t-lymphocytes - immunology (65) 65
thymoglobulin (64) 64
hematopoietic stem cell transplantation (62) 62
anemia, aplastic - drug therapy (61) 61
antilymphocyte globulin (59) 59
children (57) 57
immunosuppressive agents - adverse effects (56) 56
infant (56) 56
acute disease (54) 54
randomized-trial (54) 54
regulatory t-cells (54) 54
survival (54) 54
transplantation conditioning - methods (54) 54
graft survival (53) 53
hematopoietic stem cell transplantation - methods (51) 51
mycophenolate-mofetil (51) 51
stem cell transplantation (51) 51
t cells (51) 51
time factors (51) 51
antibodies, monoclonal - therapeutic use (50) 50
research (50) 50
follow-up studies (48) 48
hematopoietic stem cell transplantation - adverse effects (48) 48
recurrence (48) 48
survival analysis (48) 48
cyclosporine - therapeutic use (47) 47
medicine & public health (47) 47
bone marrow transplantation (46) 46
induction therapy (46) 46
pediatrics (46) 46
survival rate (45) 45
atg (44) 44
immunosuppression - methods (44) 44
leukemia (44) 44
basiliximab (42) 42
cyclophosphamide (42) 42
graft rejection - immunology (42) 42
incidence (42) 42
alemtuzumab (41) 41
kidney transplantation - immunology (41) 41
tacrolimus (41) 41
graft rejection (40) 40
rejection (40) 40
bone marrow (39) 39
prognosis (39) 39
globulins (38) 38
graft-versus-host disease (38) 38
kidneys (38) 38
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (693) 693
Russian (5) 5
French (4) 4
German (3) 3
Spanish (3) 3
Japanese (2) 2
Korean (2) 2
Portuguese (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2011, Volume 365, Issue 5, pp. 430 - 438
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 09/2010, Volume 10, Issue 9, pp. 2132 - 2141
Depletional induction therapies are routinely used to prevent acute rejection and improve transplant outcome. The effects of depleting agents on T-cell subsets... 
phenotype | Antilymphocyte antibodies | kidney allograft | T-cell depletion | pediatric renal transplant | T cell | SURGERY | RECENT THYMIC EMIGRANTS | ALLOGRAFT-REJECTION | RECEPTOR EXCISION CIRCLES | TRANSPLANT PATIENTS | DEPLETION | INDUCTION | TRANSPLANTATION | ANTI-THYMOCYTE GLOBULIN | MEMORY | EXPANSION | REGULATORY T-CELLS | T-Lymphocytes, Regulatory - metabolism | Cell Count | Humans | Middle Aged | Male | Immunologic Memory - drug effects | T-Lymphocytes, Helper-Inducer - drug effects | Flow Cytometry | Forkhead Transcription Factors - metabolism | T-Lymphocyte Subsets - drug effects | Antilymphocyte Serum - therapeutic use | Adult | Female | B-Lymphocytes - pathology | Child | Rabbits | Kidney Diseases - pathology | Kidney Transplantation | Kidney Diseases - immunology | Phenotype | T-Lymphocytes, Regulatory - drug effects | Animals | T-Lymphocyte Subsets - pathology | CD8-Positive T-Lymphocytes - drug effects | Immune System - drug effects | Adolescent | Kidney Diseases - therapy | Aged | CD4-Positive T-Lymphocytes - drug effects | Immunologic Factors - therapeutic use | Organ transplant recipients | Medical colleges | T cells | Analysis | Index Medicus | Flow cytometry | Immunological memory | Memory cells | Immune reconstitution | Foxp3 protein | Lymphocytes T | Antilymphocyte serum | CD4 antigen | Thymus
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 12/2015, Volume 125, Issue 12, pp. 4655 - 4665
Journal Article
Journal Article
Journal Article
Nephrology, ISSN 1320-5358, 08/2015, Volume 20, Issue 8, pp. 539 - 543
Journal Article
Cytotherapy, ISSN 1465-3249, 2012, Volume 14, Issue 10, pp. 1258 - 1275
Journal Article
Journal Article
BLOOD, ISSN 0006-4971, 06/2012, Volume 119, Issue 23, pp. 5391 - 5396
Rabbit antithymocyte globulin (rATG; thymoglobulin, Genzyme) in combination with cyclosporine, as first-line immunosuppressive therapy, was evaluated... 
STIMULATING FACTOR | IMMUNOSUPPRESSIVE THERAPY | ANTI-THYMOCYTE GLOBULIN | CYCLOPHOSPHAMIDE | HORSE | ALEMTUZUMAB PLUS CYCLOSPORINE | FOLLOW-UP | STEM-CELL TRANSPLANTATION | HEMATOLOGY | ALTERNATIVE DONOR | T-CELLS
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 09/2017, Volume 23, Issue 9, pp. 1498 - 1508
Journal Article